Close Menu

In this week's Science, an international team of academic and industry scientists reports a new method of modifying a therapeutic in order to visualize its activity in vitro and in vivo. The researchers demonstrated their approach on a bromodomain (BET) inhibitor  — an epigenetic drug under development for leukemia.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.